RM Lab LLC

RM Lab LLC was paid $8.17M by Medicaid between Jan 2018 and Nov 2024, across 135 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 11% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Idaho

Rank by total paid#1 of 16

Median peer was paid$8K

This provider vs. median1,075×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	52,243	$441K
2019	54,182	$470K
2020	93,449	$1.56M
2021	113,748	$2.15M
2022	117,074	$1.54M
2023	100,829	$990K
2024incomplete	92,428	$1.01M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	11%	14,446	12,357	$913K
84443	Thyroid stimulating hormone (TSH)	6.4%	38,181	36,739	$526K
80053	Comprehensive metabolic panel	4.9%	50,663	45,609	$400K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	4.6%	66,236	56,548	$377K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	4.5%	3,014	2,853	$366K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	4.5%	10,699	10,505	$365K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	4.5%	10,704	10,507	$365K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	4.2%	18,826	17,300	$347K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	3.6%	13,490	12,777	$295K
80061	Lipid panel	3.0%	22,757	21,769	$242K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	2.7%	6,911	6,801	$219K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	2.3%	5,055	4,606	$186K

123 more codes

87150		1.9%	4,762	$159K
83036	Hemoglobin; glycosylated (A1C)	1.9%	21,351	$155K
84481		1.6%	9,918	$133K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	1.6%	5,213	$132K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	1.6%	3,971	$130K
84439		1.4%	16,479	$117K
87086	Culture, bacterial; quantitative colony count, urine	1.4%	17,421	$115K
36415	Collection of venous blood by venipuncture	1.4%	48,819	$114K
82728		1.4%	9,947	$112K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	1.4%	2,798	$111K
84403		1.4%	4,828	$111K
86235		1.3%	1,136	$104K
82607		1.2%	8,008	$102K
86703		1.2%	7,821	$99K
86780		1.2%	7,952	$97K
83970		<1%	3,431	$80K
87077		<1%	10,074	$71K
80074		<1%	1,563	$66K
86762		<1%	5,055	$66K
82670		<1%	2,553	$65K
87340		<1%	6,456	$61K
84702		<1%	4,140	$61K
83525		<1%	2,465	$53K
83880		<1%	2,550	$53K
83550		<1%	7,008	$48K
88142		<1%	2,266	$44K
86850		<1%	5,408	$41K
84402		<1%	1,803	$41K
84270		<1%	1,861	$37K
87480		<1%	1,864	$37K
87510		<1%	1,860	$37K
84144		<1%	1,934	$37K
83001		<1%	2,167	$36K
83540		<1%	7,017	$35K
86480		<1%	696	$35K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	370	$34K
86696		<1%	1,513	$34K
87660		<1%	1,837	$34K
87186		<1%	5,300	$33K
87088		<1%	5,283	$31K
86803		<1%	2,421	$30K
86038		<1%	2,804	$29K
82746		<1%	2,742	$29K
83735		<1%	8,808	$27K
86140		<1%	6,281	$25K
84146		<1%	1,179	$21K
86695		<1%	1,444	$20K
80048	Basic metabolic panel (calcium, ionized)	<1%	4,316	$19K
83002		<1%	1,132	$19K
84153		<1%	1,134	$18K
82784		<1%	1,614	$17K
80159		<1%	1,577	$15K
86901		<1%	5,291	$15K
86900		<1%	5,309	$15K
80069		<1%	3,460	$14K
85652		<1%	6,835	$14K
86003		<1%	209	$14K
80164		<1%	1,536	$13K
82627		<1%	688	$13K
83516		<1%	876	$13K
82570		<1%	4,045	$12K
82951		<1%	958	$12K
86225		<1%	967	$12K
86376		<1%	886	$12K
80076		<1%	1,778	$11K
81001		<1%	6,298	$10K
84480		<1%	734	$9K
86141		<1%	889	$9K
84156		<1%	3,957	$9K
86039		<1%	846	$8K
86430		<1%	1,594	$8K
82947		<1%	1,459	$7K
85610		<1%	3,813	$7K
84703		<1%	944	$7K
80197		<1%	1,403	$7K
86364		<1%	763	$6K
82952		<1%	953	$6K
80178		<1%	1,443	$6K
88141		<1%	251	$5K
84550		<1%	1,795	$5K
86317		<1%	407	$5K
82652		<1%	138	$5K
84100		<1%	2,358	$5K
83690		<1%	844	$5K
81003		<1%	3,301	$4K
86200		<1%	315	$4K
80050	General health panel	<1%	1,001	$2K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	32	$2K
86800		<1%	144	$2K
82150		<1%	394	$2K
87506		<1%	12	$2K
83655		<1%	107	$1K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	53	$1K
86147		<1%	13	$1K
82248		<1%	244	$875.80
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	12	$792.20
85730		<1%	166	$725.07
87634		<1%	13	$701.91
86677		<1%	57	$678.60
82043		<1%	185	$670.84
86812		<1%	29	$580.75
84436		<1%	108	$549.74
85379		<1%	60	$536.52
82550		<1%	97	$458.03
83090		<1%	26	$393.71
83721		<1%	73	$370.39
86160		<1%	19	$287.82
87070		<1%	30	$262.86
87338		<1%	12	$191.76
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	15	$178.80
86060		<1%	25	$178.42
83921		<1%	12	$162.68
86231		<1%	13	$136.48
81514		<1%	81	$134.23
84460		<1%	26	$119.25
85027		<1%	27	$114.00
84630		<1%	12	$102.50
82247		<1%	14	$77.98
84478		<1%	14	$67.21
84450		<1%	12	$51.26
85018		<1%	12	$22.06
85008		0%	49	$0.00
86769		0%	79	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialCROFTS, VON (CEO)